Tirzepatide has documented improvements in blood pressure, lipids, and other cardiometabolic parameters across its phase 3 program, consistent with its degree of weight loss, and cardiovascular outcome data continue to accumulate
NAION and Semaglutide: New Research Findings Recent studies have shed light on a potential link between semaglutide use and an increased risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Physical Side Effects of Skipping Meals During GLP-1 Therapy Fasting while on semaglutide amplifies nausea, one of the most common side effects reported during the first 4-8 weeks of treatment
Sustained weight maintenance through one year: Participants maintained stable weight after a single Revita procedure, with a mean total body weight change of 5.3% 2.1% (LS means SE
For an 80kg person, this means 96-128 grams daily
It might take a minute or two